0001844030-21-000002.txt : 20210204 0001844030-21-000002.hdr.sgml : 20210204 20210203181041 ACCESSION NUMBER: 0001844030-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210204 DATE AS OF CHANGE: 20210203 EFFECTIVENESS DATE: 20210204 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Exacis Biotherapeutics Inc. CENTRAL INDEX KEY: 0001844030 IRS NUMBER: 852959151 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-388374 FILM NUMBER: 21587733 BUSINESS ADDRESS: STREET 1: 1035 CAMBRIDGE STREET STREET 2: SUITE 17B CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 1 917 415 3000 MAIL ADDRESS: STREET 1: 1035 CAMBRIDGE STREET STREET 2: SUITE 17B CITY: CAMBRIDGE STATE: MA ZIP: 02141 D 1 primary_doc.xml X0708 D LIVE 0001844030 Exacis Biotherapeutics Inc. 1035 CAMBRIDGE STREET SUITE 17B CAMBRIDGE MA MASSACHUSETTS 02141 1 917 415 3000 DELAWARE None None Corporation true 2020 Gregory Fiore 1035 Cambridge Street Suite 17B Cambridge MA MASSACHUSETTS 02141 Executive Officer Chief Executive Officer Matthew Angel 1035 Cambridge Street Suite 17B Cambridge MA MASSACHUSETTS 02141 Director Mark Corrigan 1035 Cambridge Street Suite 17B Cambridge MA MASSACHUSETTS 02141 Director Biotechnology Decline to Disclose 06b false 2021-01-22 false true Convertible Note false 25000 3000000 50000 2950000 false 1 0 0 0 false Exacis Biotherapeutics Inc. /s/ Gregory Fiore Gregory Fiore Chief Executive Officer 2021-02-03